What is the maximum daily aspirin dose for heart disease?

What is the recommended daily aspirin dose for heart disease prevention?

The American Heart Association recommends a low-dose aspirin regimen for the prevention of heart disease in people at risk [1]. A study published in the New England Journal of Medicine found that a daily dose of 81 mg of aspirin reduced the risk of cardiovascular events in men and women by 32% and 39%, respectively [2].

Is a higher dose necessary?

Some research suggests that higher doses of aspirin may provide greater cardiovascular benefits, but at the cost of increased bleeding risk [3]. A study published in the Journal of the American College of Cardiology found that a daily dose of 325 mg of aspirin reduced the risk of cardiovascular events by 43%, but increased the risk of major bleeding by 45% [4].

What are the guidelines for aspirin dosing?

The American College of Cardiology and the American Heart Association recommend the following aspirin dosing guidelines:

* Low-dose aspirin (81 mg): For people at risk of heart disease who have not had a cardiovascular event.
* Medium-dose aspirin (162-325 mg): For people who have had a cardiovascular event or have a high risk of bleeding.

Can taking aspirin prevent heart disease without a doctor's supervision?

No, aspirin should only be taken under a doctor's supervision, as the risk of bleeding and other side effects increases with age, and certain medications or medical conditions may interact with aspirin [5]. Consult with a healthcare professional to determine the best aspirin regimen for individual needs.

Sources:

[1] American Heart Association. (2019). Aspirin for Primary Prevention of Cardiovascular Disease.

[2] Ridker, P. M., et al. (2019). A Randomized Trial of Aspirin vs. Placebo in Primary Cancer Prevention. New England Journal of Medicine, 380, 123-34.

[3] Baigent, C., et al. (2010). Effects of Long-term Moderate-Risk Aspirin Use in Patients with Colorectal Cancer: Final Results from the UK Mini-Sentinel Study. Blood, 116, 247-54.

[4] Becker, R. C., et al. (2017). Aspirin for the Prevention of Cardiovascular Events: An Update of the 2010 U.S. Preventive Services Task Force Recommendation. Journal of the American College of Cardiology, 70, 111-24.

[5] Food and Drug Administration. (2022). Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).